1. Sintilimab versus placebo in combination with chemotherapy as first line treatment for locally advanced or metastatic oesophageal squamous cell carcinoma (ORIENT-15): multicentre, randomised, double blind, phase 3 trial. (19th April 2022) Authors: Lu, Zhihao; Wang, Junye; Shu, Yongqian; Liu, Lianke; Kong, Li; Yang, Lei; Wang, Buhai; Sun, Guogui; Ji, Yinghua; Cao, Guochun; Liu, Hu; Cui, Tongjian; Li, Na; Qiu, Wensheng; Li, Gaofeng; Hou, Xinfang; Luo, Hui; Xue, Liying; Zhang, Yanqiao; Yue, Wenbin Other Names: author non-byline.; Pan Zhanyu author non-byline.; Zhang Shuqun author non-byline.; Lin Gen author non-byline.; Xie Yanru author non-byline.; Li Tao author non-byline.; Ren Tiejun author non-byline.; Li Weidong author non-byline.; Gu Kangsheng author non-byline.; Wang Shoufeng author non-byline.... Journal: BMJ Issue: Volume 377(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗